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Hormones, Genes, and Cancer is a unique book, reviewing the
role of hormones in cancer etiology, treatment, and prevention.
In this book, breast and prostate cancers have been emphasized,
whereas endometrial, ovarian, and testicular cancers have been
brieﬂy discussed. This is a multiauthor book, in which experts
in a given ﬁeld were engaged successfully to review the state of
the art of research in the molecular genetics, etiology, progres-
sion, and prevention of hormone-related cancers.
It consists of 22 chapters, the ﬁrst 4 of which introduce
steroid hormones, the nuclear-receptor superfamily, and ge-
nomic approaches to hormone-responsive cancer. Estrogenme-
tabolism and breast cancer are reviewed in 10 chapters. Five
chapters are devoted to prostate cancer and androgen metab-
olism, whereas endometrial, ovarian, and testicular cancer are
each summarized in one chapter.
The ﬁrst chapter is a basic introduction to hormonal car-
cinogenesis and current trends in hormone-related cancer. This
chapter, written in a straightforward manner, gives a brief in-
troduction to the ﬁeld and is not unnecessarily detailed.
The second chapter, entitled “Biosynthesis, Transport, and
Metabolism of Steroid Hormones,” is well written and em-
phasizes the balance between production and clearance of ster-
oid hormones in the human body. The major pathways are
explained in a way that is easy to follow.
The nuclear-receptor superfamily, the largest family of tran-
scription factors, is summarized in chapter 3. Because of the
large number of members of the nuclear-receptor superfamily,
different classiﬁcation methods have been utilized, as discussed
in this chapter, including consideration of dimerization status,
DNA-binding speciﬁcity, and the nature of the chemical li-
gands. In addition to ﬁndings regarding classical steroid and
thyroid hormone receptors, studies of the function of the more
recently discovered orphan receptors, such as peroxisome pro-
liferator–activated receptors, in the proliferation of malig-
nant cells are also presented. The discussion of other aspects
of transcriptional control by nuclear receptors and by crosstalk
between nuclear receptors and other transcription factors is
very useful, since nuclear receptors can inﬂuence the activities
of other transcription factors in a positive or a negative man-
ner. The citation of more than 470 references makes this chap-
ter a good resource for those who might need additional in-
formation about any speciﬁc member of the nuclear-receptor
superfamily.
Chapter 4, “Genomic Approaches to the Genetics of Hor-
mone-Responsive Cancer,” very brieﬂy summarizes the ways
of studying cancer genetics with hormone-responsive cancer
as a model. This chapter is too concise to be useful for those
in the cancer genomics ﬁeld. However, it gives an overview of
different approaches that could be applied to cancers that are
not hormone dependent. Although not discussed in great de-
tail, recent developments in techniques increasingly utilized by
many investigators in the last decade—such as gene expression
microarrays, RNA interference approaches, and SNP technol-
ogy—are described. One can understand the difﬁculty—and
perhaps the impossibility—of covering recent developments in
these ﬁelds in a book, because of the revolution in genomics
and human genetics that has followed the presentation of ﬁrst-
draft sequences of the whole human genome in early 2001.
This chapter should lead the reader toward the possibility of
exploring a variety of approaches. In that respect, it should
attract physicians and other investigators who wish to increase
their awareness of different approaches in the ﬁeld but do not
need an extensive, detailed discussion.
Breast cancer is emphasized the most in this book, because
it is not only the most common cancer in women worldwide
but also the most widely studied hormone-related cancer. It is
reviewed extensively in 10 chapters, including sections dealing
with its molecular endocrinology, the relationship between
exogenous hormone use and breast cancer risk, estrogen bio-
synthesis, the relationship between metabolism and breast
cancer predisposing genes, families that carry BRCA1 and/or
BRCA2, studies of hormonal approaches to prevention, and
progression from hormone-dependent to hormone-indepen-
dent disease. Chemoprevention with tamoxifen and estrogen
receptor modulators is summarized in one chapter that covers
pilot studies and clinical trials around the world. The review
of estrogen biosynthesis genes, including P-450 aromatase and
estrogen metabolism genes (HSD 17B1 and HSD 17B2) is very
informative, in that it reveals molecules that might be involved
in breast cancer pathogenesis. This is a good overview for those
entering this ﬁeld.
Prostate cancer epidemiology and molecular endocrinology,
androgen receptor signaling, hereditary prostate cancer, an-
drogen-independent prostate cancer progression, and hor-
monal therapies for prostate cancer are reviewed in subsequent
chapters. These chapters are very well written by the experts
in their ﬁelds. They cover most of the recent developments in
prostate cancer genetics and androgen metabolism. However,
recent ﬁndings on germline mutations in the ribonuclease L
gene, a candidate HPC1 gene at 1q25, have not been included
in the section on hereditary prostate cancer, in which the au-
thors present studies on major prostate cancer susceptibility
loci. Another drawback of the book is the variation in the
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interpretations of conﬂicting ﬁndings in different chapters,
which is not uncommon in multiauthor books. For example,
in one chapter, the authors emphasize the association of the
androgen receptor CAG repeat with the risk of developing
prostate cancer. They mostly dismiss the other studies that
could not ﬁnd such a correlation, suggesting that this failure
could be due to small sample sizes, population differences, and/
or failure to appropriately match cases and controls in such
studies. However, in the next chapter, different authors review
this area and conclude that no evidence for association between
CAG repeats and prostate cancer risk was observed. Although
this conﬂict has the potential to confuse the reader, it might
actually be helpful to show that such correlation is not yet
clear, thereby leading investigators to perform more research
on the subject.
The last three chapters review endometrial, ovarian, and
testicular cancers, and, for the most part, they cover epi-
demiology and molecular endocrinology of these diseases.
Overall, I wholeheartedly recommend Hormones, Genes,
and Cancer to the physicians, investigators, and students in
the ﬁelds of genetics, endocrinology, and oncology. I think each
of them will ﬁnd much in this book that will be beneﬁcial.
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